SCHEMBL6497928

SCHEMBL6497928

Cc1cc(C=CC(=O)N2CCC(C(=O)NC(C)C(=O)O)CC2)ccc1F

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CAPN1 P07384 4/20 0.48
NPC1 O15118 8/20 0.46
RAB9A P51151 8/20 0.46
SMN1; SMN2 Q16637 4/20 0.45
GPR183 P32249 2/20 0.45
POLB P06746 1/20 0.44
ALDH1A1 P00352 1/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
MAOB P27338 1/20 0.43
GAA P10253 1/20 0.41
CCR2 P41597 2/20 0.41
APOBEC3A P31941 1/20 0.41
APOBEC3G Q9HC16 1/20 0.41
ITGB2 P05107 1/20 0.40
ICAM1 P05362 1/20 0.40
ITGAL P20701 1/20 0.40
KDM4E B2RXH2 1/20 0.40
LMNA P02545 1/20 0.40
MAPT P10636 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6497923 1.00 CAPN1 (0.48) CAPN1NPC1RAB9ASMN1; SMN2GPR183
SCHEMBL6499373 0.90 CAPN1 (0.48) CAPN1NPC1RAB9ASMN1; SMN2GPR183
SCHEMBL6499376 0.90 CAPN1 (0.48) CAPN1NPC1RAB9ASMN1; SMN2GPR183
SCHEMBL6495756 0.87 CAPN1 (0.47) CAPN1NPC1RAB9ASMN1; SMN2GPR183
SCHEMBL6495765 0.87 CAPN1 (0.47) CAPN1NPC1RAB9ASMN1; SMN2GPR183
SCHEMBL6500056 0.84 CAPN1 (0.50) CAPN1NPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL6500054 0.84 CAPN1 (0.50) CAPN1NPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL6497650 0.83 NPC1 (0.60) CAPN1NPC1RAB9APOLBALDH1A1
SCHEMBL6498081 0.82 CAPN1 (0.43) CAPN1NPC1RAB9ASMN1; SMN2POLB
SCHEMBL6498087 0.82 CAPN1 (0.43) CAPN1NPC1RAB9ASMN1; SMN2POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005016883-A2 ACRYLAMIDE DERIVATIVES AS VLA-1 INTEGRIN ANTAGONISTS AND USES THEREOF ICOS CORPORATION (US) 2005-02-24 WO claimed
WO-2005016883-A2 ACRYLAMIDE DERIVATIVES AS VLA-1 INTEGRIN ANTAGONISTS AND USES THEREOF ICOS CORPORATION (US) 2005-02-24 WO disclosed